Ustekinumab 45MG/0.5ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0K4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,701
Award facts
- Contract value 100% obligated
- $15,701.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,701.10 delivery order to Amerisourcebergen Drug Corp on April 3, 2026, for Ustekinumab 45mg/0.5ml syringes, with an ultimate completion date of April 24, 2026.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price, and no set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F0K4H?
SPE2DR26F0K4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 3, 2026.
How much is contract SPE2DR26F0K4H worth?
The government has obligated $15,701 on SPE2DR26F0K4H.
Is contract SPE2DR26F0K4H an order under another contract?
Yes. SPE2DR26F0K4H is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0K4H competed?
The extent of competition for SPE2DR26F0K4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award